LYL1 and acute lymphoblastic leukemia: Targets of ZFP36L2 include oncogenes and tumor suppressors, such as NOTCH1, EZH2, MYC, SPI.1, LMO2, LYL1, and TAL1. Interestingly, ZFP36L2 knock-out mice develop T-ALL [29].